Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast Cancer
NCT04941885
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
78
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus AI
Sponsor
Sun Yat-sen University